I am having trouble getting lentiviral infection of two Burkitt Lymphoma cell lines -- Raji and Daudi -- using pLentiCRISPR v2 (and a couple v1) constructs containing sgRNA's. Here's an overview of my protocol:
* Plasmids are mini-prepped with multiple preps pooled per plasmid.
* cRPMI = RPMI 1640 + 10% FBS + L-Glut + HEPES + Pen/Strep
Day 0: Seed a 6-well plate with ~7.5E5 293T cells in 2 mL cRPMI
Day 1: Transfect ~60-80% confluent 293T cells in 6 well plate with XTREMEGene HP transfection reagent with the following complex after 20 min room-temp incubation: 1200 ng pLentiCRISPR, 900 ng pdeltaVpr, 300 ng pVSV-G in 180 uL OptiMEM + 6 uL HP reagent
Day 2: Replace media with cRPMI (since the viral supernatant will be used for suspension cell transductions)
Day 4: Harvest lentiviral supernatant and passed through 0.45 um filter, 1E6 Raji/Daudi cells are re-suspended in harvested viral supernatant and spinoculated in 8 ug/mL polybrene, 2220 rpm, at 30 degrees for 45 minutes
Day 5: Replace media with cRPMI
Day 7: Raji/Daudi are selected with 2 ug/mL Puromycin for three days whereupon assays begin.
Unfortunately, I am unable to get any of my Raji or Daudi cells to survive puro selection.
I have cloned in an emGFP gene into the pLentiCRISPRv2 backbone and have been able to generate about 40% GFP from just the XTREMEGene transfection (after 48 hrs) of 293T. However, I am unable to get a GFP signal from my Raji/Daudi cells 72 hrs post-transduction.
Does anyone know of easy pitfalls I may be falling into? I am trying to keep my protocol as is since I am trying to replicate an experiment that followed this protocol. The only internal steps are doing the lentiviral production in cRPMI and the selection concentration was determined empirically.
I would really appreciate words of lentiviral wisdom!!